4.6 Article Proceedings Paper

Safety and feasibility of esophagectomy following combined immunotherapy and chemoradiotherapy for esophageal cancer

Related references

Note: Only part of the references are listed.
Review Multidisciplinary Sciences

Neoadjuvant checkpoint blockade for cancer immunotherapy

Suzanne L. Topalian et al.

SCIENCE (2020)

Article Respiratory System

Adjuvant and Neoadjuvant Immunotherapy in Non - small Cell Lung Cancer

Stephen R. Broderick

THORACIC SURGERY CLINICS (2020)

Review Oncology

The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment

Jake S. O'Donnell et al.

CLINICAL CANCER RESEARCH (2019)

Article Oncology

The Current Status of Immunotherapies in Esophagogastric Cancer

Geoffrey Y. Ku

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)

Review Oncology

Esophageal and Esophagogastric Junction Cancers, Version 2.2019

Jaffer A. Ajani et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Cardiac & Cardiovascular Systems

Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer

Matthew J. Bott et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)

Article Multidisciplinary Sciences

Integrated genomic characterization of oesophageal carcinoma

Jihun Kim et al.

NATURE (2017)

Article Biochemistry & Molecular Biology

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Ahmet Zehir et al.

NATURE MEDICINE (2017)

Article Medicine, General & Internal

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer

SG Swisher et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2000)